NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Neuropace, Inc. (NPCE)
Company Research
Source: Business Wire
-- Reported record quarterly revenue of $27.4 million in Q3 2025 representing 30% growth ---- Increased full-year 2025 revenue guidance to between $97 million and $98 million and gross margin guidance to between 76% and 77% ---- Remains on track to submit NAUTILUS PMA Supplement to FDA for IGE indication expansion by year-end 2025 -- MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update.Third Quarter 2025 Financial HighlightsTotal revenue of $27.4 million, representing growth of 30% compared to the third quarter of 2024RNS® System revenue of $22.6 million, representing growth of 31% compared to the third quarter of 2024Delivered strong gross margin of 77.4% driven by positive product mix and manufacturing efficienciesThird Quarter 2025 Operational & Strategic High
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual MeetingBusiness Wire
- NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient ServicesBusiness Wire
- NeuroPace (NPCE) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NASDAQ:NPCE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/4/25 - Beat
NPCE
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 4
- NPCE's page on the SEC website